PPP1R13L is a known inhibitor of P53 and takes an important position in the progression and chemoresistance of several cancers.[25] High PPP1R13L expression results in the inhibition of the P53 signaling pathway, leading to reduced rates of apoptosis and increased drug resistance. The gene discussed is PPP1R13L; the disease is cancer.